November 19, 2018
Stages of Change – A Summary of Treatment Needs and Strategies https://www.csam-asam.org/sites/default/files/pdf/misc/StagesofChange.pdf
ADHD
Methylphenidate Hydrochloride Extended Release Tablets (generic Concerta) made by Mallinckrodt and Kudco https://www.fda.gov/Drugs/DrugSafety/ucm422568.htm
September 24, 2018
Adult ADHD
CADDRA ADHD Assessment Toolkit https://www.caddra.ca/etoolkit-forms/
Alcohol use disorder
Smartphone Apps
Meredith, S. E., Alessi, S. M., & Petry, N. M. (2015). Smartphone applications to reduce alcohol consumption and help patients with alcohol use disorder: a state-of-the-art review. Advanced Health Care Technologies, 1, 47–54. doi:10.2147/AHCT.S65791 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963021/
Penzenstadler L, Chatton A, Van Singer M, Khazaal Y,. (2016). Quality of Smartphone Apps Related to Alcohol Use Disorder. European Addiction Research, 22(6), 329-338 https://www.karger.com/Article/FullText/449097#
Harm Reduction and Managed Alcohol Programs
Podymow,T., Turnbull,J., Coyle,D., Yetisir,E.,& Wells,G. (2006). Shelter-based managed alcohol administration to chronically homeless people addicted to alcohol, CMAJ, 174 (1) 45-49; DOI: 10.1503/cmaj.1041350 http://www.cmaj.ca/content/174/1/45.full
Pauly, B. (Bernie), Gray, E., Perkin, K., Chow, C., Vallance, K., Krysowaty, B., & Stockwell, T. (2016). Finding safety: a pilot study of managed alcohol program participants’ perceptions of housing and quality of life. Harm Reduction Journal, 13, 15. http://doi.org/10.1186/s12954-016-0102-5
Grant, S., Watkins, K. E., Bogart, A., Paddock, S. M., & Hepner, K. A. (2016). Patient-Reported Offers of Alcohol Treatment for Primary Care Patients at High-Risk for an Alcohol Use Disorder. Journal of the American Board of Family Medicine : JABFM, 29(6), 682–687. Doi:10.3122/jabfm.2016.06.160023 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234830/
Behavioral Strategies
Lamb, R. J., Maguire, D. R., Ginsburg, B. C., Pinkston, J. W., & France, C. P. (2016). Determinants of choice, and vulnerability and recovery in addiction. Behavioural Processes, 127, 35–42. doi: 10.1016/j.beproc.2016.04.001 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968700/
Leisure/ Life Skills
Miriam Boeri, Megan Gardner, Erin Gerken, Melissa Ross, Jack Wheeler, (2016) “I don’t know what fun is”: examining the intersection of social capital, social networks, and social recovery. Drugs and Alcohol Today,16(1), 95-105, doi:10.1108/DAT-08-2015-0046 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029464/
Best,D., Irving,J., Collinson,B., Andersson,C., & Edwards,M. (2016). Recovery networks and community connections: identifying connection needs and community linkage opportunities in early recovery populations. Alcoholism Treatment Quarterly, 35(1), 2-15, DOI: 10.1080/07347324.2016.1256718 http://shura.shu.ac.uk/14272/ [Final accepted version. Might differ slightly from final published version]
Gabapentin
Mason BJ, Quello S, Goodell V, Shadan F, Kyle M, Begovic A. Gabapentin Treatment for Alcohol DependenceA Randomized Clinical Trial. JAMA Intern Med. 2014;174(1):70–77. doi:10.1001/jamainternmed.2013.11950 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1764009
Schifano, F.(2014). Misuse and Abuse of Pregabalin and Gabapentin: Cause for Concern? CNS Drugs 28(6), 491-496 https://doi.org/10.1007/s40263-014-0164-4
Home Detox
Healing at home: Developing a model for ambulatory alcohol "detox" in an Aboriginal community controlled health service. https://journals.uvic.ca/index.php/ijih/article/view/16906
Functions of Use
Annabel Boys, John Marsden, John Strang; Understanding reasons for drug use amongst young people: a functional perspective, Health Education Research, Volume 16, Issue 4, 1 August 2001, Pages 457–469, https://doi.org/10.1093/her/16.4.457
Blumenthal, H., Leen-Feldner, E. W., Frala, J. L., Badour, C. L., & Ham, L. S. (2010). Social Anxiety and Motives for Alcohol Use among Adolescents. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors, 24(3), 529–534. http://doi.org/10.1037/a0019794
Sinclair Method
Website https://www.the-sinclair-method.com/
John David Sinclair; Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism, Alcohol and Alcoholism, Volume 36, Issue 1, 1 January 2001, Pages 2–10, https://doi.org/10.1093/alcalc/36.1.2
Relationships and alcohol
Ciubară, A., Burlea, Ş. L., Săcuiu, I., Radu, D. A., Untu, I., & Chiriţă, R. (2015). Alcohol Addiction–A Psychosocial Perspective. Procedia-Social and Behavioral Sciences, 187, 536-540. https://doi.org/10.1016/j.sbspro.2015.03.100
Wyrzykowska, E., Głogowska, K., & Mickiewicz, K. (2014). Attachment relationships among alcohol dependent persons. Alcoholism and Drug Addiction, 27(2), 145-161. https://doi.org/10.1016/S0867-4361(14)70010-0
Emslie, C., Hunt, K., & Lyons, A. (2015). Transformation and time-out: The role of alcohol in identity construction among Scottish women in early midlife. International Journal of Drug Policy, 26(5), 437-445. https://doi.org/10.1016/j.drugpo.2014.12.006
Not open access
Rodriguez, L. M., Knee, C. R., & Neighbors, C. (2014). Relationships can drive some to drink: Relationship-contingent self-esteem and drinking problems. Journal of Social and Personal Relationships, 31(2), 270-290. https://doi.org/10.1177%2F0265407513494037
November 26, 2018
CCSA Chronic Illness and Alcohol Infographic http://www.ccsa.ca/Resource%20Library/CCSA-Chronic-Illness-and-Alcohol-Infographic-2014-en.pdf
Low-Risk Alcohol Drinking Guidelines Communications Toolkit http://www.ccdus.ca/Eng/topics/alcohol/drinking-guidelines-communications-toolkit/Pages/default.aspx
The Lancet (April 2018) Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies https://doi.org/10.1016/S0140-6736(18)30134-X
The Lancet (August 2018) No level of alcohol consumption improves health https://doi.org/10.1016/S0140-6736(18)31571-X
Alcohol and Nicotine
Nadra E. Lisha, Timothy P. Carmody, Gary L. Humfleet, Kevin L. Delucchi,. (2014). Reciprocal effects of alcohol and nicotine in smoking cessation treatment studies. Addictive Behaviors, Volume 39, Issue 3,Pages 637-643, http://europepmc.org/articles/pmc3906916
Novembr 5th, 2018
O'haire, M. E., Guérin, N. A., & Kirkham, A. C. (2015). Animal-assisted intervention for trauma: A systematic literature review. Frontiers in psychology, 6, 1121. https://doi.org/10.3389/fpsyg.2015.01121
Naste, T. M., Price, M., Karol, J., Martin, L., Murphy, K., Miguel, J., & Spinazzola, J. (2018). Equine Facilitated Therapy for Complex Trauma (EFT-CT). Journal of child & adolescent trauma, 11(3), 289-303. https://doi.org/10.1007/s40653-017-0187-3
Antipsychotics and Comorbid Substance Use
Koola, M. M., Wehring, H. J., & Kelly, D. L. (2012). The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use. Journal of Dual Diagnosis, 8(1), 50–61. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383636/
Benzodiazepines
Ashton, H. (2002). Benzodiazepines: How they work and how to withdraw (aka The Ashton Manual). https://www.benzo.org.uk/manual/index.htm
Anthierens, S., et al. (2010). Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia: Family physicians’ attitudes toward benzodiazepine prescribing. Canadian Family Physician, 56 (11) e398 e406 http://www.cfp.ca/content/56/11/e398ijkey=d2d1514afba5c32b53cc35edcf91b6356cf49b0b&keytype2=tf_ipsecsha
Fixsen, A., & Ridge, D. (2017). Stories of Hell and Healing: Internet Users’ Construction of Benzodiazepine Distress and Withdrawal. Qualitative Health Research, 27(13), 2030-2041 DOI: 10.1177/1049732317728053 http://westminsterresearch.wmin.ac.uk/19772/ [open access eprint, might differ slightly from final published article]
National Center for PTSD. (2013). Helping patients taper from benzodiazepines. https://www.va.gov/PAINMANAGEMENT/docs/OSI_6_Toolkit_Taper_Benzodiazepines_Clinicians.pdf
Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of Inappropriate Benzodiazepine Prescriptions Among Older Adults Through Direct Patient EducationThe EMPOWER Cluster Randomized Trial. JAMA Intern Med. 2014;174(6):890–898. doi:10.1001/jamainternmed.2014.949
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1860498
Canadian Centre on Substance Abuse. (2014). Effective interventions to manage symptoms of benzodiazepine withdrawal in seniors. http://www.ccsa.ca/Resource%20Library/CCSA-Benzodiazepine-Withdrawal-Seniors-Rapid-Review-2014-en.pdf
Bibliotherapy for addiction
Ward, J. (2017). What is bibliotherapy for addiction? Society for the Study of Addiction https://www.addiction-ssa.org/commentary/what-is-...-bibliotherapy
Fanner, D. and Urquhart, C. (2008), Bibliotherapy for mental health service users Part 1: a systematic review. Health Information & Libraries Journal, 25: 237-252. doi:10.1111/j.1471-1842.2008.00821.x
R4R@Rutgers: Reading for Recovery LibGuide https://libguides.rutgers.edu/R4R
Suggested books
Yost, J.T. (Ed.).Bottoms-Up! True Tales of Hitting Rock Bottom. (2017). Birdcage Bottom Books. https://www.goodreads.com/book/show/36121372-bottoms-up-true-tales-of-hitting-rock-bottom
Knapp, C. (1997). Drinking: a Love Story. Dial Press https://www.goodreads.com/book/show/73965.Drinking?ac=1&from_search=true
Santora, P., Dowell, M., & Hennigfield, J. (Eds.) (2010). Addiction and Art. Johns Hopkins University Press https://jhupbooks.press.jhu.edu/content/addiction-and-art
Nabigon, H. (2006). The Hollow Tree. McGill-Queen’s University Press http://www.mqup.ca/hollow-tree--the-products-9780773531321.php
LaBoucane-Benson,P. (2015). The Outside Circle. House of Anansi Press https://houseofanansi.com/products/the-outside-circle
Haines, S. (2015). Trauma is Really Strange. Singing Dragon https://singingdragon.com/can/trauma-is-really-strange-33899.html
Haines, S. (2017). Pain is Really Strange. Singing Dragon https://singingdragon.com/can/pain-is-really-strange-3.html
September 24, 2018
Bipolar Disorder
Ellen Forney (2018) Rock Steady: Brilliant advice from my bipolar life. http://www.fantagraphics.com/rocksteady/
Graphic novel with tips for managing bipolar disorder
Oct 1, 2018
Mood Disorder Questionnaire (MDQ) - Screening tool for bipolar disorder https://www.integration.samhsa.gov/images/res/MDQ.pdf
November 26, 2018
Sagar, K. A., Dahlgren, M. K., Racine, M. T., Dreman, M. W., Olson, D. P., & Gruber, S. A. (2016). Joint effects: a pilot investigation of the impact of bipolar disorder and marijuana use on cognitive function and mood. PloS one, 11(6), e0157060. https://doi.org/10.1371/journal.pone.0157060
Agrawal, A., Nurnberger Jr, J. I., Lynskey, M. T., & Study, T. B. G. (2011). Cannabis involvement in individuals with bipolar disorder. Psychiatry research, 185(3), 459-461. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2976789/
Dec 10, 2018
Effects of Marijuana on Mental Health: Bipolar Disorder. Alcohol and Drug Abuse Institute, University of Washington http://adai.uw.edu/pubs/pdf/2017mjbipolar.pdf
Cerimele, J. M., Bauer, A. M., Fortney, J. C., & Bauer, M. S. (2017). Patients With Co-Occurring Bipolar Disorder and Posttraumatic Stress Disorder: A Rapid Review of the Literature. The Journal of clinical psychiatry, 78(5), e506-e514.https://www.psychiatrist.com/jcp/article/Pages/2017/v78n05/v78n0505.aspx
Life course of bipolar disorder
Dols, A., Kupka, R., Kessing, L. V., Stek, M., & Sajatovic, M. (2011). Bipolar disorder in the elderly. Aging Health, 7(6), 797-800. https://doi.org/10.2217/ahe.11.75
Sajatovic, M., Strejilevich, S. A., Gildengers, A. G., Dols, A., Al Jurdi, R. K., Forester, B. P., Kessing, L. V., Beyer, J., Manes, F., Rej, S., Rosa, A. R., Schouws, S. N., Tsai, S. Y., Young, R. C., … Shulman, K. I. (2015). A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force. Bipolar disorders, 17(7), 689-704.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623878/
Kessing LV, Andersen PK. (2004). Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? Journal of Neurology, Neurosurgery & Psychiatry;75:1662-1666https://jnnp.bmj.com/content/75/12/1662.long
Stop Walking on Eggshells – Paul Mason https://books.google.ca/books/about/Stop_Walking_on_Eggshells.html?id=UFrAvF2Bj-cC
I Hate You, Don’t Leave Me – Jerold Jay Kreisman & Hal Straus https://books.google.ca/books/about/I_Hate_You_Don_t_Leave_Me.html?id=e7NDDwAAQBAJ&redir_esc=y
Get me out of here – Rachel Reiland https://books.google.ca/books?id=GwbXDQAAQBAJ&source=gbs_book_other_versions
Cloitre, M., et al. (2014). Distinguishing PTSD, Complex PTSD, and Borderline Personality Disorder: A latent class analysis. European Journal of Psychotraumatology, 5(1) https://doi.org/10.3402/ejpt.v5.25097
September 24, 2018
Maclean Screening Instrument for BPD http://www.ottawadepressionalgorithm.ca/download/81_2y10LlGhwqBLL1mkWdDTyn7XecYzOx
November 26, 2018
NICE guidelines- Borderline Personality Disorder: Recognition and Management (CG78). London, U.K.: National Institute for Health and Care Excellence; 2009 https://www.nice.org.uk/guidance/CG78
National Institute for Health and Care Excellence – Personality Disorders Overview: http://pathways.nice.org.uk/pathways/personality-disorders
American Psychiatric Association – Guideline for the Treatment of Patients with Borderline Personality Disorder (2001): http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/bpd.pdf
The Canadian Network for Mood and Anxiety Treatments (CANMAT) 2012 task force recommendations for the management of patients with mood disorders and comorbid personality disorders. https://www.ncbi.nlm.nih.gov/pubmed/22303522 http://canmat.org/canmatpub.html [Not open access – need to request full-text pdf]
Oct 1, 2018
Open access
Anderson, T. A., Quaye, A. N., Ward, E. N., Wilens, T. E., Hilliard, P. E., & Brummett, C. M. (2017). To Stop or Not, That Is the Question: Acute Pain Management for the Patient on Chronic Buprenorphine. Anesthesiology: The Journal of the American Society of Anesthesiologists, 126(6), 1180-1186. http://anesthesiology.pubs.asahq.org/article.aspx?articleid=2618834
Not open access
White, L. D., Hodge, A., Vlok, R., Hurtado, G., Eastern, K., & Melhuish, T. M. (2017). The efficacy and adverse effects of buprenorphine in acute pain management: a systematic review and meta-analysis of randomised controlled trials. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2017.11.086
October 29, 2018
Burnout and compassion fatigue
Open access
Montero-Marin, J., Zubiaga, F., Cereceda, M., Demarzo, M. M. P., Trenc, P., & Garcia-Campayo, J. (2016). Burnout subtypes and absence of self-compassion in primary healthcare professionals: A cross-sectional study. PloS one, 11(6), e0157499. https://doi.org/10.1371/journal.pone.0157499
Not open access
Rossi, A., Cetrano, G., Pertile, R., Rabbi, L., Donisi, V., Grigoletti, L., ... & Amaddeo, F. (2012). Burnout, compassion fatigue, and compassion satisfaction among staff in community-based mental health services. Psychiatry Research, 200(2-3), 933-938. https://doi.org/10.1016/j.psychres.2012.07.029
Lying Down in the Ever-Falling Snow: Canadian Health Professionals' Experience of Compassion Fatigue, by Wendy Austin, E. Sharon Brintnell, Erika Goble, Leon Kagan, Linda Kreitzer, Denise J. Larsen, and Brendan Leier https://www.wlupress.wlu.ca/Books/L/Lying-Down-in-the-Ever-Falling-Snow
Self-care
Crane, P. J., & Ward, S. F. (2016). Self-healing and self-care for nurses. AORN journal, 104(5), 386-400. https://www.aorn.org/websitedata/cearticle/pdf_file/CEA16539-0001.pdf
Coaston, S. C. (2017). Self-Care through Self-Compassion: A Balm for Burnout. The Professional Counselor, 7(3), 285-297. https://eric.ed.gov/?id=EJ1165683
Developing Your Self Care Plan - From the University of Buffalo, Social of Social Work: https://socialwork.buffalo.edu/resources/self-care-starter-kit/developing-your-self-care-plan.html
Using mindfulness to soothe physician stress (2013) American Medical News http://www.amednews.com/article/20130107/profession/130109974/4/
Adverse events
Scott, S. D., Hirschinger, L. E., Cox, K. R., McCoig, M., Brandt, J., & Hall, L. W. (2009). The natural history of recovery for the healthcare provider “second victim” after adverse patient events. BMJ Quality & Safety, 18(5), 325-330. http://dx.doi.org/10.1136/qshc.2009.032870
Cannabis
Fernández Mayo, L. et al. (2015). Dual Pathology: Craving and drug abuse in patients on Paliperidone, European Psychiatry, 30(1), 1064 DOI: https://doi.org/10.1016/S0924-9338(15)30839-7
June 25th session
Effects of Marijuana on Mental Health: Bipolar Disorder. Alcohol and Drug Abuse Institute, University of Washington http://adai.uw.edu/pubs/pdf/2017mjbipolar.pdf
Effects of Marijuana on Mental Health: Attention Deficit-Hyperactivity Disorder (ADHD). Alcohol and Drug Abuse Institute, University of Washington http://adai.uw.edu/pubs/pdf/2017mjadhd.pdf
September 17th Session
Galli, J. A., Sawaya, R. A., & Friedenberg, F. K. (2011). Cannabinoid Hyperemesis Syndrome. Current Drug Abuse Reviews, 4(4), 241–249. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/
September 24, 2018
Open Access
Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370(23), 2219-2227. https://www.nejm.org/doi/full/10.1056/nejmra1402309
Ramaekers, J. G. (2018). Driving Under the Influence of Cannabis: An Increasing Public Health Concern. JAMA, 319(14), 1433-1434. https://jamanetwork.com/journals/jama/fullarticle/2676931
The effects of cannabis use during adolescence (2015) http://www.ccsa.ca/Resource%20Library/CCSA-Effects-of-Cannabis-Use-during-Adolescence-Report-2015-en.pdf
Health Impacts of Cannabis CCSA http://www.ccsa.ca/Eng/topics/Cannabis/Health-Impacts-of-Cannabis/Pages/default.aspx
- DeRosse, A. Kaplan, K.E. Burdick, T. Lencz, A.K. Malhotra (2010) Cannabis use disorders in schizophrenia: effects on cognition and symptoms. Schizophr. Res., 120 (1–3), pp. 95-100 http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2902262&blobtype=pdf
Not Open Access
Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004). Review of the validity and significance of cannabis withdrawal syndrome. American journal of Psychiatry, 161(11), 1967-1977. https://www.ncbi.nlm.nih.gov/pubmed/15514394
George, T. P., Hill, K. P., & Vaccarino, F. J. (2018). Cannabis Legalization and Psychiatric Disorders: Caveat “Hemp-tor”. The Canadian Journal of Psychiatry, 0706743718762387. http://journals.sagepub.com/doi/abs/10.1177/0706743718762387
Dickson, B., Mansfield, C., Guiahi, M., Allshouse, A. A., Borgelt, L. M., Sheeder, J., ... & Metz, T. D. (2018). Recommendations From Cannabis Dispensaries About First-Trimester Cannabis Use. Obstetrics & Gynecology. https://journals.lww.com/greenjournal/Abstract/publishahead/Recommendations_From_Cannabis_Dispensaries_About.98083.aspx
Mitch Earleywine, Rachel Luba, Melissa N. Slavin, Stacey Farmer & Mallory Loflin (2016) Don’t wake and bake: morning use predicts cannabis problems. Addiction Research & Theory, 24:5, 426-430, DOI: 10.1080/16066359.2016.1177027
Oct 1, 2018
Legalisation
Rapid Synthesis: Examining the Impact of Decriminalizing or Legalizing Cannabis for Recreational Use (2017). McMaster Health Forum https://www.mcmasterforum.org/docs/default-source/product-documents/rapid-responses/examining-the-impact-of-decriminalizing-or-legalizing-cannabis-for-recreational-use.pdf?sfvrsn=10
Osborne, G. B., & Fogel, C. (2017). Perspectives on cannabis legalization among Canadian recreational users. Contemporary Drug Problems, 44(1), 12-31. http://journals.sagepub.com/doi/10.1177/0091450916670393
Not open access
Reinarman, C., Nunberg, H., Lanthier, F., & Heddleston, T. (2011). Who are medical marijuana patients? Population characteristics from nine California assessment clinics. Journal of psychoactive drugs, 43(2), 128-135. https://doi.org/10.1080/02791072.2011.587700
Mental health
Blanco, C., Hasin, D. S., Wall, M. M., Flórez-Salamanca, L., Hoertel, N., Wang, S., ... & Olfson, M. (2016). Cannabis use and risk of psychiatric disorders: prospective evidence from a US national longitudinal study. JAMA psychiatry, 73(4), 388-395. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2491944
Appetite
Jager, G., & Witkamp, R. (2014). The endocannabinoid system and appetite: Relevance for food reward. Nutrition Research Reviews, 27(1), 172-185. doi:10.1017/S0954422414000080 https://www.cambridge.org/core/journals/nutrition-research-reviews/article/endocannabinoid-system-and-appetite-relevance-for-food-reward/30C65E719848770761B6BEA7D0C1E9CB
Guidelines
Lower risk Cannabis Use Guidelines – Health Professionals https://www.camh.ca/-/media/files/lrcug_professional-pdf
Lower risk cannabis use guidelines – Public https://www.camh.ca/-/media/files/pdfs---reports-and-books---research/canadas-lower-risk-guidelines-cannabis-pdf.pdf
CPSO Marijuana for Medical Purposes https://www.cpso.on.ca/Policies-Publications/Policy/Marijuana-for-Medical-Purposes
Sleep
Open access
Linares, I. M. P., Guimaraes, F. S., Eckeli, A., Crippa, A. C. S., Zuardi, A. W., Souza, J. D. S., … Crippa, J. A. S. (2018). No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. Frontiers in Pharmacology, 9, 315. http://doi.org/10.3389/fphar.2018.00315
Miller, S. (2017). In search of efficacy: A self-reported patient study identifying effective THC: CBD ratios for sleep, pain and arousal based on dose-controlled delivery of vaporized cannabis oil. Poster presented at CannMed Conference 2017. http://www.cannmedevents.com/wp-content/uploads/2017/05/Samantha-Miller-cannmed_poster_48x48_final_R6_.pdf [BIAS WARNING: author runs both a cannabis testing lab and a company that produces dose-controlled cannabis products]
Not open access
Babson, K.A., Sottile, J. & Morabito, D. Curr. (2017). Cannabis, cannabinoids and sleep: A review of the literature, Psychiatry Rep 19: 23. https://doi.org/10.1007/s11920-017-0775-9
November 26, 2018
Health Canada (2018). Information for Health Care Professionals: Cannabis (marihuana, marijuana) and the cannabinoids https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/information-medical-practitioners/information-health-care-professionals-cannabis-cannabinoids.html
Health Canada (2016) Access to Cannabis for Medical Purposes Regulations - Daily Amount Fact Sheet (Dosage) https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/information-medical-practitioners/cannabis-medical-purposes-regulations-daily-amount-fact-sheet-dosage.html
Allan, G. M., Ramji, J., Perry, D., Ton, J., Beahm, N. P., Crisp, N., ... & Fleming, M. (2018). Simplified guideline for prescribing medical cannabinoids in primary care. Canadian Family Physician, 64(2), 111-120. http://www.cfp.ca/content/64/2/111
Not open access
Walsh, Z., Gonzalez, R., Crosby, K., Thiessen, M. S., Carroll, C., & Bonn-Miller, M. O. (2017). Medical cannabis and mental health: A guided systematic review. Clinical psychology review, 51, 15-29. https://doi.org/10.1016/j.cpr.2016.10.002
Case formulation is the process of blending a theoretical framework and scientific knowledge with the unique experience of the client, to help understand presenting issues and select the optimum treatment.
“Developing a complete picture of a client by collecting data that are used to generate hypotheses about the causes, antecedents and maintaining influences for an individual’s problems, within a bio-psycho-social framework” (Christon et al., 2015)
Case Formulation Worksheet – Please download and use to support in developing the client narrative.
Ware, Mark A. Boulanger, Aline et al.(2015). Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). The Journal of Pain, Volume 16, Issue 12, 1233 – 1242 https://doi.org/10.1016/j.jpain.2015.07.014
October 29, 2018
Open access
Pain, hedonic regulation, and opioid misuse: Modulation of momentary experience by Mindfulness-Oriented Recovery Enhancement in opioid-treated chronic pain patients https://doi.org/10.1016/j.drugalcdep.2016.07.033
Marion Lee, M., Sanford Silverman, M., Hans Hansen, M., & Vikram Patel, M. D. (2011). A comprehensive review of opioid-induced hyperalgesia. Pain physician, 14, 145-161. http://www.painphysicianjournal.com/linkout?issn=1533-3159&vol=14&page=145
Not open access
Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies doi: 10.1097/j.pain.0000000000001293
Managing pain before it manages you 4th ed. (2016). https://www.guilford.com/books/Managing-Pain-Before-It-Manages-You/Margaret-Caudill/9781462522774/reviews
November 19, 2018
Challenges for healthcare providers
Chang, J. S., Kushel, M., Miaskowski, C., Ceasar, R., Zamora, K., Hurstak, E., & Knight, K. R. (2017). Provider experiences with the identification, management, and treatment of co-occurring chronic noncancer pain and substance use in the safety net. Substance use & misuse, 52(2), 251-255. https://europepmc.org/articles/pmc5345572
Not open access
Knight, K. R., Kushel, M., Chang, J. S., Zamora, K., Ceasar, R., Hurstak, E., & Miaskowski, C. (2017). Opioid pharmacovigilance: A clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use. Social Science & Medicine, 186, 87-95. https://doi.org/10.1016/j.socscimed.2017.05.043
Guideline
The 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain http://nationalpaincentre.mcmaster.ca/guidelines.html
Dec 10, 2018
Wiffen PJ, Derry S, Bell RF, Rice ASC, Tölle TR, Phillips T, Moore RA. (2017). Gabapentin for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews, Issue 6. Art. No.: CD007938. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007938.pub4
Hesselstrand, M., Samuelsson, K., and Liedberg, G. (2015) Occupational Therapy Interventions in Chronic Pain – A Systematic Review. Occup. Ther. Int., 22: 183–194. https://doi.org/10.1002/oti.1396
Cognitive Processing Therapy
US Department of Veterans Affairs. (2017). Cognitive Processing for PTSD [for the public] https://www.ptsd.va.gov/public/treatment/therapy-med/cognitive_processing_therapy.asp
Resick, P., Chard, K., & Monson, C. (n.d.). Cognitive Processing Therapy – official website https://cptforptsd.com/
Kaysen, D., Schumm, J., Pedersen, E. R., Seim, R. W., Bedard-Gilligan, M., & Chard, K. (2014). Cognitive Processing Therapy for Veterans with Comorbid PTSD and Alcohol Use Disorders. Addictive Behaviors, 39(2), 10.1016/j.addbeh.2013.08.016. doi:10.1016/j.addbeh.2013.08.016 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855895/
ACToronto. Staying off Crystal: For a day or longer http://www.actoronto.org/health-information/young-people/staying-off-crystal.pdf
McCall Hannah, Adams Naomi, Mason David, WillisJamie. What is chemsex and why does it matter? BMJ 2015; 351 :h5790 https://www.bmj.com/content/351/bmj.h5790.full
Smith Vivienne, Tasker Fiona (2017) Gay men’s chemsex survival stories. Sexual Health 15, 116-122. Doi: 10.1071/SH17122 http://eprints.bbk.ac.uk/21463/ [open access pre-print]
Complicated Grief
Shear, M. K. (2012). Grief and mourning gone awry: pathway and course of complicated grief. Dialogues in Clinical Neuroscience, 14(2), 119–128. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384440/
Shear, M. K., Simon, N., Wall, M., Zisook, S., Neimeyer, R., Duan, N., … Keshaviah, A. (2011). Complicated grief and related bereavement issues for DSM-5. Depression and Anxiety, 28(2), 103–117. http://doi.org/10.1002/da.20780
Countertransference
Linn-Walton, R., & Pardasani, M. (2014). Dislikable Clients or Countertransference: A Clinician’s Perspective. The Clinical Supervisor, 33(1), 100–121. Doi:10.1080/07325223.2014.924693 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364528/
Oct 15, 2018
National Survey on Drug Use and Health (2016) Key Substance Use and Mental Health Indicators in the United States https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2016/NSDUH-FFR1-2016.pdf
Comorbidity: Substance Use Disorders and Other Mental Illnesses (2018) National institute on Drug Abuse https://www.drugabuse.gov/publications/drugfacts/comorbidity-substance-use-disorders-other-mental-illnesses
Global Appraisal of Individual Needs (GAIN) Short Screener http://gaincc.org/instruments/
Not open access
Rush, B., Urbanoski, K., Bassani, D., Castel, S., Wild, T. C., Strike, C., ... & Somers, J. (2008). Prevalence of co-occurring substance use and other mental disorders in the Canadian population. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 53(12), 800. https://www.ncbi.nlm.nih.gov/pubmed/19087478
Rush, B., & Koegl, C. J. (2008). Prevalence and profile of people with co-occurring mental and substance use disorders within a comprehensive mental health system. The Canadian Journal of Psychiatry, 53(12), 810-821. https://www.ncbi.nlm.nih.gov/pubmed/19087479
September 24, 2018
Open Access
The Forensic Mental Health System in Canada: An information guide. (2008) CAMH Publications https://www.camh.ca/-/media/files/guides-and-publications/forensic-guide-en.pdf
Not Open Access
Wilton, G., & Stewart, L. A. (2017). Outcomes of offenders with co-occurring substance use disorders and mental disorders. Psychiatric services, 68(7), 704-709. https://ps.psychiatryonline.org/doi/full/10.1176/appi.ps.201500391
McPherson, S. M., Burduli, E., Smith, C. L., Herron, J., Oluwoye, O., Hirchak, K., Orr, M. F., McDonell, M. G., … Roll, J. M. (2018). A review of contingency management for the treatment of substance-use disorders: adaptation for underserved populations, use of experimental technologies, and personalized optimization strategies. Substance abuse and rehabilitation, 9, 43-57. doi:10.2147/SAR.S138439 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095117/
Petry, N. (2011). Contingency management: what it is and why psychiatrists should want to use it. The Psychiatrist, 35(5), 161-163. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083448/
Developmental Disorders
Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges. NICE guideline [NG11] Published date: May 2015 https://www.nice.org.uk/guidance/ng11
Sheehan, R., Hassiotis,A., Walters,K., Osborn,D., Strydom,A., Horsfall,L., et al.(2015). Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study BMJ, 351 :h4326 https://www.bmj.com/content/351/bmj.h4326
Family Support and ASD (not Open Access - abstract only)
Spain D, Sin J, Paliokosta E, Furuta M, Prunty JE, Chalder T, Murphy DG, Happé FG.(2017). Family therapy for autism spectrum disorders. Cochrane Database of Systematic Reviews , Issue 5. Art. No.: CD011894. DOI: 10.1002/14651858.CD011894.pub2 http://www.cochrane.org/CD011894/BEHAV_family-therapy-autism-spectrum-disorders
Banach,M., Iudice,J., Conway,L., & Couse,L. (2010). Family support and empowerment: post autism diagnosis support group for parents. Social Work with Groups, 33(1), 69-83 https://doi.org/10.1080/01609510903437383
Mulligan, J., MacCulloch, R., Good, B., & Nicholas, D. (2012). Transparency, hope, and empowerment: A model for partnering with parents of a child With Autism Spectrum Disorder at diagnosis and beyond. Social Work in Mental Health, 10(4), 311-330 https://doi.org/10.1080/15332985.2012.664487
June 25th session
Koerner, K. (2011). Doing Dialectical Behavior Therapy: A practical guide https://www.guilford.com/books/Doing-Dialectical-Behavior-Therapy/Kelly-Koerner/9781462502325/summary
Linehan, M. DBT Skills Training Manual https://www.guilford.com/books/DBT-Skills-Training-Manual/Marsha-Linehan/9781462516995
Linehan, M. DBT Skills Training Handouts and Worksheets https://www.guilford.com/books/DBT-Skills-Training-Handouts-and-Worksheets/Marsha-Linehan/9781572307810/summary
September 17th session
Dimeff, L. A., & Linehan, M. M. (2008). Dialectical Behavior Therapy for Substance Abusers. Addiction Science & Clinical Practice, 4(2), 39–47. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797106/
Carmel, A., Rose, M., & Fruzzetti, A. E. (2014). Barriers and Solutions to Implementing Dialectical Behavior Therapy in a Public Behavioral Health System. Administration and Policy in Mental Health, 41(5), 608–614. Doi: 10.1007/s10488-013-0504-6 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835762/
Not Open Access
Mastering the Art of Chain Analysis in Dialectical Behavior Therapy https://doi.org/10.1016/j.cbpra.2013.09.002
Lynch, et al (2006) Mechanisms of change in dialectical behavior therapy: theoretical and empirical observations. https://www.ncbi.nlm.nih.gov/pubmed/16470714 [cited in didactic]
November 12
Powell, K., Wilcox, J., Clonan, A., Bissell, P., Preston, L., Peacock, M., & Holdsworth, M. (2015). The role of social networks in the development of overweight and obesity among adults: a scoping review. BMC Public Health, 15(1), 996. https://doi.org/10.1186/s12889-015-2314-0
Not open access
Jeynes, K. D., & Gibson, E. L. (2017). The importance of nutrition in aiding recovery from substance use disorders: A review. Drug and alcohol dependence, 179, 229-239. https://doi.org/10.1016/j.drugalcdep.2017.07.006
Dual Diagnosis
Espen Ajo Arnevik and Sissel Berge Helverschou. (2016). Autism Spectrum Disorder and Co-occurring Substance Use Disorder – A Systematic Review. Substance Abuse: Research and Treatment. https://doi.org/10.4137/SART.S39921
Butwicka, A., Långström, N., Larsson, H. et al.(2017). Increased Risk for Substance Use-Related Problems in Autism Spectrum Disorders: A Population-Based Cohort Study. J Autism Dev Disord . 47: 80. https://doi.org/10.1007/s10803-016-2914-2
Oct 15, 2018
Fetal Alcohol Spectrum Disorders (FASD) – Overview and Resources https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/fetal-alcohol-spectrum-disorder
Temple, V. K., Ives, J., & Lindsay, A. (2015). Diagnosing FASD in adults: the development and operation of an adult FASD clinic in Ontario, Canada. Journal of population therapeutics and clinical pharmacology= Journal de la therapeutique des populations et de la pharamcologie clinique, 22(1), e96-e105. http://www.jptcp.com/articles/diagnosing-fasd-in-adults-the-development-and-operation-of-an-adult-fasd-clinic-in-ontario-canada.pdf
Fetal alcohol spectrum disorder: a guideline for diagnosis across the lifespan (2015) http://www.cmaj.ca/content/cmaj/188/3/191.full.pdf
Popova, S., Lange, S., Chudley, A. E., Reynolds, J. N., & Rehm, J. (2018). World Health Organization International Study on the Prevalence of Fetal Alcohol Spectrum Disorder (FASD). Canadian Component. https://canfasd.ca/wp-content/uploads/sites/35/2018/05/2018-Popova-WHO-FASD-Prevalance-Report.pdf
September 24, 2018
Head Injury
Not open access
Head Injury as Risk Factor for Psychiatric Disorders: A Nationwide Register-Based Follow-Up Study of 113,906 Persons With Head Injury” from the American Journal of Psychiatry: http://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2013.13020190
Guidelines
Safe prescribing practices for addictive medications and management of substance use disorders in primary care: A pocket reference for family physicians. Meldon Kahan (2017). http://www.womenscollegehospital.ca/assets/pdf/MetaPhi/2017-04-03%20PCP%20pocket%20guide.pdf
Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain. http://nationalpaincentre.mcmaster.ca/opioid/cgop_b05_r21.html
October 29, 2018
Open access
Feng, L. Y., Battulga, A., Han, E., Chung, H., & Li, J. H. (2017). New psychoactive substances of natural origin: A brief review. Journal of Food and Drug Analysis, 25(3), 461-471. https://doi.org/10.1016/j.jfda.2017.04.001
NIDA (2018). What is kratom? https://www.drugabuse.gov/publications/drugfacts/kratom
Not open access
Swogger, M. T., & Walsh, Z. (2017). Kratom use and mental health: A systematic review. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2017.10.012
November 26, 2018
Lucca, J. M., Ramesh, M., Parthasarathi, G., & Ram, D. (2015). Incidence and factors associated with medication nonadherence in patients with mental illness: a cross-sectional study. Journal of postgraduate medicine, 61(4), 251-6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943371/
Motivational Interviewing
Lawrence P, Fulbrook P, Somerset S, Schulz P. Motivational interviewing to enhance treatment attendance in mental health settings: A systematic review and meta‐analysis. J Psychiatr Ment Health Nurs. 2017;24:699–718. https://doi.org/10.1111/jpm.12420
Syzdek, M. R., Addis, M. E., Green, J. D., Whorley, M. R., & Berger, J. (2014). A Pilot Trial of Gender-Based Motivational Interviewing for Help-Seeking and Internalizing Symptoms in Men. Psychology of Men & Masculinity, 15(1), 90–94. http://doi.org/10.1037/a0030950
Selby, P. (2014). The 4 principles of motivational interviewing. https://youtu.be/C02a_rAIho0
Opioid Use Disorders
Lagisetty, P., Klasa, K., Bush, C., Heisler, M., Chopra, V., & Bohnert, A. (2017). Primary care models for treating opioid use disorders: What actually works? A systematic review. PLoS ONE, 12(10), e0186315. http://doi.org/10.1371/journal.pone.0186315
Buprenorphine – home induction
Lee, J. D., Grossman, E., DiRocco, D., & Gourevitch, M. N. (2009). Home Buprenorphine/Naloxone Induction in Primary Care. Journal of General Internal Medicine, 24(2), 226–232. Doi: 10.1007/s11606-008-0866-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628995/
Cunningham, C. O., Giovanniello, A., Li, X., Kunins, H. V., Roose, R. J., & Sohler, N. L. (2011). A comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions. Journal of Substance Abuse Treatment, 40(4), 349–356. Doi: 10.1016/j.jsat.2010.12.002 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081891/
Withdrawal management
British Columbia Centre on Substance Use and B.C. Ministry of Health. A Guideline for the Clinical Management of Opioid Use Disorder. Published June 5, 2017. Available at: http://www.bccsu.ca/care-guidance-publications/ [withdrawal management p20, residential treatment p21
BRITISH COLUMBIA OVERDOSE ACTION EXCHANGE Supplementary Material: Primers JULY 2016 http://www.bccdc.ca/resource-gallery/Documents/BCOAE-supplementary-materials.pdf [inpatient withdrawal management and residential treatment p28]
Dennis McCarty, Kelsey C. Priest, P. Todd Korthuis. (2018). Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities Annual Review of Public Health 39:1, 525-541
Bruneau, J., et al.(2018). Management of opioid use disorders: a national clinical practice guideline. CMAJ 2018 March 5;190:E247-57. doi: 10.1503/cmaj.170958 http://www.cmaj.ca/content/cmaj/190/9/E247.full.pdf
Barriers to treatment
Bacchus, L., Strang, J., & Watson, P. Pathways to Abstinence: Two-Year Follow-Up Data on 60 Abstinent Former Opiate Addicts Who Had Been Turned Away from Treatment. Eur Addict Res 2000;6:141-147 https://www.karger.com/Article/Abstract/19026#
Stumbo, Scott P. et al. (2017). Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement. Journal of Substance Abuse Treatment , Volume 73 , 47 - 54 https://doi.org/10.1016/j.jsat.2016.11.003
Vancouver case studies
Jade Boyd, Danya Fast, Megan Hobbins, Ryan McNeil and Will Small. (2017). Social-structural factors influencing periods of injection cessation among marginalized youth who inject drugs in Vancouver, Canada: an ethno-epidemiological study. Harm Reduction Journal,14:31 https://doi.org/10.1186/s12954-017-0159-9
Susan Boyd, Dave Murray, SNAP2 and Donald MacPherson. (2017). Telling our stories: heroin-assisted treatment and SNAP activism in the Downtown Eastside of Vancouver. Harm Reduction Journal,14:27 https://doi.org/10.1186/s12954-017-0152-3
Oct 15, 2018
Kennedy, L. C., Binswanger, I. A., Mueller, S. R., Levy, C., Matlock, D. D., Calcaterra, S. L., ... & Frank, J. W. (2017). “Those Conversations in My Experience Don’t Go Well”: A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications. Pain Medicine. https://www.ncbi.nlm.nih.gov/pubmed/29126138
Katt, M., Chase, C., Samokhvalov, A. V., Argento, E., Rehm, J., & Fischer, B. (2013). Feasibility and Outcomes of a Community-Based Taper-to-Low-Dose-Maintenance Suboxone Treatment Program for Prescription Opioid Dependence in a Remote First Nations Community in Northern Ontario. International Journal of Indigenous Health, 9(1), 52-59. https://journals.uvic.ca/index.php/ijih/article/view/12394
November 12
BMI and food preferences
Fenn, J. M., Laurent, J. S., & Sigmon, S. C. (2015). Increases in body mass index following initiation of methadone treatment. Journal of substance abuse treatment, 51, 59-63. DOI:10.1016/j.jsat.2014.10.007 http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC4346498&blobtype=pdf
Mysels, D. J., & Sullivan, M. A. (2010). The relationship between opioid and sugar intake: review of evidence and clinical applications. Journal of opioid management, 6(6), 445-52. Mario https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109725/
Not Open Access
Peles, E., Schreiber, S., Sason, A., & Adelson, M. (2016). Risk factors for weight gain during methadone maintenance treatment. Substance abuse, 37(4), 613-618. https://doi.org/10.1080/08897077.2016.1179705
November 19, 2018
Opioid Toolkit. Portico (2015) https://www.porticonetwork.ca/web/opioid-toolkit
CADTH Opioid Evidence Bundle (2018) https://cadth.ca/evidence-bundles/opioid-evidence-bundle
Kaye, A. D., Jones, M. R., Kaye, A. M., Ripoll, J. G., Galan, V., Beakley, B. D., ... & Manchikanti, L. (2017). Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1. Pain physician, 20(2S), S93. http://www.painphysicianjournal.com/linkout?issn=1533-3159&vol=20&page=S93#
Hypogonadism
De Maddalena, C., Bellini, M., Berra, M., Meriggiola, M. C., & Aloisi, A. M. (2012). Opioid-induced hypogonadism: why and how to treat it. Pain Physician, 15(3), ES111-ES118. http://www.painphysicianjournal.com/linkout?issn=1533-3159&vol=15&page=ES111
Not open access
Hsieh, A., DiGiorgio, L., Fakunle, M., & Sadeghi-Nejad, H. (2018). Management Strategies in Opioid Abuse and Sexual Dysfunction: A Review of Opioid-Induced Androgen Deficiency. Sexual medicine reviews. https://doi.org/10.1016/j.sxmr.2018.04.003
Birthi, P., Nagar, V. R., Nickerson, R., & Sloan, P. A. (2015). Hypogonadism associated with long-term opioid therapy: A systematic review. Journal of opioid management, 11(3), 255-278. http://dx.doi.org/10.5055/jom.2015.0274
Bernese Method
Hämmig, R., Kemter, A., Strasser, J., von Bardeleben, U., Gugger, B., Walter, M., Dürsteler, K. M., … Vogel, M. (2016). Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method. Substance abuse and rehabilitation, 7, 99-105. doi:10.2147/SAR.S109919 https://doi.org/10.2147/SAR.S109919
Guidelines
The 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain http://nationalpaincentre.mcmaster.ca/guidelines.html
December 3, 2018
Management in hospital settings
CPSO (2011) MMT Program Standards and Clinical Guidelines https://www.cpso.on.ca/Policies-Publications/CPGs-Other-Guidelines/Methadone-Program/MMT-Program-Standards-and-Clinical-Guidelines
Noska, A., Mohan, A., Wakeman, S., Rich, J., & Boutwell, A. (2015). Managing Opioid Use Disorder During and After Acute Hospitalization: A Case-Based Review Clarifying Methadone Regulation for Acute Care Settings. Journal of addictive behaviors, therapy & rehabilitation, 4(2), 1000138. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527170/
Fanucchi, L., & Lofwall, M. R. (2016). Putting parity into practice–Integrating opioid-use disorder treatment into the hospital setting. https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1000&context=chsr_facpub
Suzuki, J., DeVido, J., Kalra, I., Mittal, L., Shah, S., Zinser, J., & Weiss, R. D. (2015). Initiating buprenorphine treatment for hospitalized patients with opioid dependence: a case series. The American journal on addictions, 24(1), 10-14. https://doi.org/10.1111/ajad.12161
Not open access
Hassamal, S., Goldenberg, M., Ishak, W., Haglund, M., Miotto, K., & Danovitch, I. (2017). Overcoming barriers to initiating medication-assisted treatment for heroin use disorder in a general medical hospital: A case report and narrative literature review. Journal of psychiatric practice, 23(3), 221-229. https://doi.org/10.1097/PRA.0000000000000231
Velez, C.M., Nicolaidis, C., Korthuis, P.T. et al. (2017). “It’s been an Experience, a Life Learning Experience”: A Qualitative Study of Hospitalized Patients with Substance Use Disorders. J GEN INTERN MED (2017) 32: 296. https://doi.org/10.1007/s11606-016-3919-4
Dec 10, 2018
Withdrawal management
Srivastava, A., Kahan, M., & Nader, M. (2017). Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?. Canadian family physician, 63(3), 200-205. http://www.cfp.ca/content/63/3/200.full
Murphy, L., Babaei-Rad, R., Buna, D., Isaac, P., Murphy, A., Ng, K., Regier, L., Steenhof, N., Zhang, M., … Sproule, B. (2018). Guidance on opioid tapering in the context of chronic pain: Evidence, practical advice and frequently asked questions. Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC, 151(2), 114-120. doi:10.1177/1715163518754918 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843113/
Clearing the Smoke on Cannabis: Maternal Cannabis Use during Pregnancy – An Update (2018) http://www.ccsa.ca/Resource%20Library/CCSA-Cannabis-Maternal-Use-Pregnancy-Report-2018-en.pdf
Volkow ND, Compton WM, Wargo EM. The Risks of Marijuana Use During Pregnancy. JAMA. 2017;317(2):129–130. doi:10.1001/jama.2016.18612 https://jamanetwork.com/journals/jama/fullarticle/2594400
Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., ... & Fischer, G. (2010). Neonatal abstinence syndrome after methadone or buprenorphine exposure. New England Journal of Medicine, 363(24), 2320-2331. https://www.nejm.org/doi/full/10.1056/nejmoa1005359
WHO (2014) Guidelines for the identification and management of substance use and substance use disorders in pregnancy https://www.who.int/substance_abuse/publications/pregnancy_guidelines/en/
Wendy V. Norman, Edith R. Guilbert, Christopher Okpaleke, Althea S. Hayden, E. Steven Lichtenberg, Maureen Paul, Katharine O’Connell White and Heidi E. Jones (2016) Abortion health services in Canada: Results of a 2012 national survey Canadian Family Physician, 62 (4) e209-e217 http://www.cfp.ca/content/62/4/e209?sid=3010fd8e-85a8-45a5-9561-c07f089936fe
November 26, 2018
Canvas RX - A database of Canadian Medical Marijuana products https://canvasrx.com/
SwitchRx – online medication switching tool https://switchrx.ca/
CredibleMeds – mobile app and website – QT drugs database https://crediblemeds.org/blog/crediblemeds-launches-mobile-app-expand-access-online-qtdrug/
November 5, 2018
Hypertension medication (propranolol)
Fitzgerald, P. J., Giustino, T. F., Seemann, J. R., & Maren, S. (2015). Noradrenergic blockade stabilizes prefrontal activity and enables fear extinction under stress. Proceedings of the National Academy of Sciences, 201500682. https://doi.org/10.1073/pnas.1500682112 [summary and commentary https://www.futurity.org/blood-pressure-drug-ptsd-fear-957702/
Giustino, T. F., Fitzgerald, P. J., & Maren, S. (2016). Revisiting propranolol and PTSD: memory erasure or extinction enhancement?. Neurobiology of learning and memory, 130, 26-33. http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC4818733&blobtype=pdf
Not Open AccessBrunet, A., Saumier, D., Liu, A., Streiner, D. L., Tremblay, J., & Pitman, R. K. (2018). Reduction of PTSD symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. American Journal of Psychiatry, 175(5), 427-433. https://doi.org/10.1176/appi.ajp.2017.17050481
November 12
Lee, D. J., Schnitzlein, C. W., Wolf, J. P., Vythilingam, M., Rasmusson, A. M., & Hoge, C. W. (2016). Psychotherapy Versus Pharmacotherapy For Posttraumatic Stress Disorder: Systemic Review And Meta-Analyses To Determine First-Line Treatments. https://digitalcommons.unl.edu/usuhs/166/
Watkins, L. E., Sprang, K. R., & Rothbaum, B. (2018). Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions. Frontiers in Behavioral Neuroscience, 12, 258. https://doi.org/10.3389/fnbeh.2018.00258
Guidelines
Clinical Practice Guideline for the Treatment of PTSD (2017). APA https://www.apa.org/ptsd-guideline/ptsd.pdf
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., & Van Ameringen, M. (2014). Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC psychiatry, 14(1), S1. https://doi.org/10.1186/1471-244X-14-S1-S1
Scales and Screening tools
PTSD Checklist for DSM-5 (PCL-5) https://www.ptsd.va.gov/professional/assessment/adult-sr/ptsd-checklist.asp
Nightmares
Nightmares and PTSD https://www.ptsd.va.gov/understand/related/nightmares.asp
Morgenthaler, T. I., Auerbach, S., Casey, K. R., Kristo, D., Maganti, R., Ramar, K., Zak, R., … Kartje, R. (2018). Position Paper for the Treatment of Nightmare Disorder in Adults: An American Academy of Sleep Medicine Position Paper. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 14(6), 1041-1055. doi:10.5664/jcsm.7178 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991964/
Open Access
Integrated Exposure-Based Therapy for Co-occurring Posttraumatic Stress Disorder and Substance Dependence: A Randomized Controlled Trial (2012) https://jamanetwork.com/journals/jama/fullarticle/1346186
Integrated Exposure-Based Therapy for Co-Occurring Post Traumatic Stress Disorder (PTSD) and Substance Dependence: Predictors of Change in PTSD Symptom Severity (2016) http://www.mdpi.com/2077-0383/5/11/101/htm
The Co-Occurrence of PTSD and Opioid Use Disorder in Opioid Agonist Therapy
http://www.apa.org/pubs/highlights/podcasts/episode-26.aspx [based on the 2017 article below]
Not Open Access
Posttraumatic stress disorder in opioid agonist therapy: A review. (2017) http://psycnet.apa.org/doi/10.1037/tra0000312
Lisa M. Najavits, Martha Schmitz, Silke Gotthardt & Roger D. Weiss (2005) Seeking Safety Plus Exposure Therapy: An Outcome Study on Dual Diagnosis Men, Journal of Psychoactive Drugs, 37:4, 425-435, DOI: 10.1080/02791072.2005.10399816
Psychological interventions for post-traumatic stress disorder and comorbid substance use disorder: A systematic review and meta-analysis (2015) https://www.sciencedirect.com/science/article/pii/S0272735815000380
November 26, 2018
The Chief Public Health Officer’s Report on the State of Public Health in Canada 2018: Preventing Problematic Substance Use in Youth https://www.canada.ca/en/public-health/corporate/publications/chief-public-health-officer-reports-state-public-health-canada/2018-preventing-problematic-substance-use-youth.html
Canadian Guidelines for the Assessment and Diagnosis of Patients with Schizophrenia Spectrum and Other Psychotic Disorders: http://journals.sagepub.com/doi/pdf/10.1177/0706743717719899
Guidelines for the Pharmacotherapy of Schizophrenia in Adults: http://journals.sagepub.com/doi/pdf/10.1177/0706743717720448
Canadian Treatment Guidelines on Psychosocial Treatment of Schizophrenia in Adults: http://journals.sagepub.com/doi/pdf/10.1177/0706743717719894
Substance Use
Stéphanie Baggio, Stanislas Spilka, Joseph Studer, Katia Iglesias & Gerhard Gmel (2016) Trajectories of drug use among French young people: Prototypical stages of involvement in illicit drug use, Journal of Substance Use, 21:5, 485-490, DOI: 10.3109/14659891.2015.1063720
World Health Organization. The ASSIST project - Alcohol, Smoking and Substance Involvement Screening Test. http://www.who.int/substance_abuse/activities/assist/en/ [Includes a guide with brief interventions for use in primary care, and self-help guide]
Impaired at work: A guide to accommodating substance dependence. Canadian Human Rights Commission (2017) https://www.chrc-ccdp.gc.ca/sites/default/files/impaired_at_work.pdf
Medical Consequences
Devlin, R. J., & Henry, J. A. (2008). Clinical review: Major consequences of illicit drug consumption. Critical Care, 12(1), 202. https://ccforum.biomedcentral.com/articles/10.1186/cc6166
Larney, S., Peacock, A., Mathers, B. M., Hickman, M., & Degenhardt, L. (2017). A systematic review of injecting-related injury and disease among people who inject drugs. Drug and alcohol dependence, 171, 39-49. Doi: 10.1016/j.drugalcdep.2016.11.029 https://research-information.bristol.ac.uk/files/144642844/IRID_review_2016_06_08.pdf [pre-print from institutional repository]
Methamphetamine
Obermeit, L. C., Cattie, J. E., Bolden, K. A., Marquine, M. J., Morgan, E. E., Franklin Jr, D. R., ... & Translational Methamphetamine AIDS Research Center (TMARC) Group. (2013). Attention-deficit/hyperactivity disorder among chronic methamphetamine users: frequency, persistence, and adverse effects on everyday functioning. Addictive behaviors, 38(12), 2874-2878. http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC3805791&blobtype=pdf
Not open access
Moeller, F. G., Schmitz, J. M., Herin, D., & Kjome, K. L. (2008). Use of stimulants to treat cocaine and methamphetamine abuse. Current psychiatry reports, 10(5), 385-391. https://doi.org/10.1007/s11920-008-0062-x
November 5, 2018
Goodman, R. (2017). Trauma Theory and Trauma-Informed Care in Substance Use Disorders: A Conceptual Model for Integrating Coping and Resilience. Advances in Social Work, 18(1), 186-201. https://doi.org/10.18060/21312
Seeking Safety website https://www.treatment-innovations.org/seeking-safety.html
Adverse Childhood Experiences (SAMHSA) https://www.samhsa.gov/capt/practicing-effective-prevention/prevention-behavioral-health/adverse-childhood-experiences
Nadine Burke Harris (2014) How childhood trauma affects health across a lifetime. TEDMED https://www.tedmed.com/talks/show?id=293066
Vicky Kelly (2014) The paradox of trauma-informed care. TEDxWilmington http://www.tedxwilmington.com/speakers/vicky-kelly/
November 5, 2018
Zanolli, L. (2018, Nov 7). Can people be saved from a terrible childhood? The Guardian (UK) https://www.theguardian.com/world/commentisfree/2018/nov/07/ace-adverse-childhood-experience-trauma
Empowering Families Affected by Substance Use Problems
- Free online course for Families affected by substance use offered by CAMH